Patel Naimish
CIK: 0002021679•Chief Medical Officer
Officer
Primary company: CRISPR Therapeutics AG (CRSP)
Patel Naimish is a corporate insider (Chief Medical Officer) at CRISPR Therapeutics AG (CRSP) filing SEC Form 4 transactions. 15 transactions, totaling $49,704 in purchases and $141,316 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 56,328 | $13.94 | $785K | 56,328 | 9/11/2026 Filed: 9/11/2026 | Filing → | |
CRISPR Therapeutics AG CRSP | Sale | 3,786 | $55.62 | $211K | 19,357 | 5/29/2026 Filed: 5/28/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Exercise | 10,000 | - | - | 20,000 | 5/28/2026 Filed: 5/28/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Exercise | 10,000 | - | - | 23,143 | 5/28/2026 Filed: 5/28/2026 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 16,500 | - | - | 16,500 | 10/3/2025 Filed: 10/3/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 25,000 | - | - | 25,000 | 5/30/2025 Filed: 6/3/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Sale | 3,932 | $35.94 | $141K | 6,068 | 5/29/2025 Filed: 5/30/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Exercise | 10,000 | - | - | 30,000 | 5/28/2025 Filed: 5/30/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Exercise | 10,000 | - | - | 10,000 | 5/28/2025 Filed: 5/30/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Purchase | 1,508 | $32.96 | $50K | 1,508 | 4/3/2025 Filed: 4/3/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 32,500 | - | - | 32,500 | 3/14/2025 Filed: 3/18/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 46,667 | $42.12 | $1.97M | 46,667 | 3/14/2025 Filed: 3/18/2025 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 18,333 | - | - | 18,333 | 10/16/2024 Filed: 10/18/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 40,000 | - | - | 40,000 | 5/28/2024 Filed: 5/29/2024 | Filing → |
CRISPR Therapeutics AG CRSP | Award | 85,000 | - | - | 85,000 | 5/28/2024 Filed: 5/29/2024 | Filing → |
Type
Award
Shares
56,328
Price
$13.94
Value
$785K
CRISPR Therapeutics AG
CRSP
Type
Sale
Shares
3,786
Price
$55.62
Value
$211K
CRISPR Therapeutics AG
CRSP
Type
Exercise
Shares
10,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Exercise
Shares
10,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
16,500
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
25,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Sale
Shares
3,932
Price
$35.94
Value
$141K
CRISPR Therapeutics AG
CRSP
Type
Exercise
Shares
10,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Exercise
Shares
10,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Purchase
Shares
1,508
Price
$32.96
Value
$50K
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
32,500
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
46,667
Price
$42.12
Value
$1.97M
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
18,333
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
40,000
Price
-
Value
-
CRISPR Therapeutics AG
CRSP
Type
Award
Shares
85,000
Price
-
Value
-
AI Agent
Try asking...